ADCT

Dopo l'orario di chiusura: 1.11

Adc Therapeutics Sa (ADCT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Adc Therapeutics Sa Stock (ADCT) Company Profile

Adc Therapeutics Sa

Healthcare (1069)

41 21 653 02 00

BIOPOLE, EPALINGES

Prossima data di guadagno

Ultimi documenti SEC

ADCT's Discussions on Twitter

Compare ADCT vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADCT Adc Therapeutics Sa	1.11	155.75M	79.18M	-136.99M	-120.11M	-1.0547
TAK Takeda Pharmaceutical Co Adr	18.11	58.15B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.35	42.94B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.22	40.59B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	72.86	30.29B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	503.86	21.74B	3.17B	1.29B	1.01B	27.09

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-08	Iniziato	Stephens	Overweight
2024-05-30	Iniziato	Cantor Fitzgerald	Overweight
2024-03-28	Iniziato	Guggenheim	Buy
2023-08-10	Aggiornamento	JP Morgan	Underweight → Neutral
2023-04-24	Downgrade	BofA Securities	Neutral → Underperform
2022-12-06	Iniziato	CapitalOne	Overweight
2022-11-09	Downgrade	BofA Securities	Buy → Neutral
2022-09-21	Iniziato	JP Morgan	Overweight
2022-09-09	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-09	Iniziato	Wolfe Research	Outperform
2021-08-17	Ripresa	Jefferies	Buy
2021-08-09	Iniziato	RBC Capital Mkts	Outperform
2021-06-15	Iniziato	Cantor Fitzgerald	Overweight
2020-12-03	Iniziato	Stifel	Hold
2020-10-29	Iniziato	H.C. Wainwright	Buy
2020-06-09	Iniziato	BofA/Merrill	Buy
2020-06-09	Iniziato	Cowen	Outperform

Mostra tutto

Adc Therapeutics Sa Borsa (ADCT) Ultime notizie

Adc Therapeutics Sa Azioni (ADCT) Dati Finanziari

Adc Therapeutics Sa (ADCT)

Adc Therapeutics Sa Stock (ADCT) Company Profile

Compare ADCT vs TAK, TEVA, HLN, ZTS, UTHR

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

Adc Therapeutics Sa Borsa (ADCT) Ultime notizie

ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.9%Time to Sell? - MarketBeat

ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Morningstar

ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses - Yahoo Finance

ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript - AOL.com

ADC Therapeutics SA (NYSE:ADCT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Following a 56% Decline Over Last Year, Recent Gains May Please ADC Therapeutics SA (NYSE:ADCT) Institutional Owners - 富途牛牛

Guggenheim cuts ADC Therapeutics stock price target on FDA concerns By Investing.com - Investing.com South Africa

symbol__ Stock Quote Price and Forecast - CNN

Antibody-Drug Conjugates (ADC) Market Set to Witness Significant - The National Law Review

ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook - Yahoo Finance

ADC Therapeutics (NYSE:ADCT) Rating Increased to Hold at Wall Street Zen - MarketBeat

Nantahala group discloses 9.69% ADC Therapeutics (ADCT) ownership in 13G filing - Stock Titan

ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says - marketscreener.com

ADC Therapeutics Reports Q2 2026 Results, Reassesses ZYNLONTA Path - The Globe and Mail

ADC Therapeutics S.A. Q2 2026 Earnings Call Summary - Yahoo Finance

ADCT|ADC Therapeutics SA|Price:1.050|Chg%:-0.180 - TradingKey

ADC Therapeutics SA (ADCT) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles ... - Yahoo! Finance Canada

ADC Therapeutics SA (ADCT) Latest Stock News & Headlines - Yahoo Finance

ADC Therapeutics Q2 Earnings Call Highlights - MarketBeat

ADC Therapeutics (NYSE:ADCT) Posts Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat

ADC Therapeutics SA: Shareholders Board Members Managers and Company Profile | CH0499880968 - marketscreener.com

ADC Therapeutics Q2 Results: Net Loss Falls 71% to $16.6 Million - scanx.trade

Form 8K ADC Therapeutics SA For: 13 August By Investing.com - Investing.com Nigeria

ADC Therapeutics SA reports results for the quarter ended June 30Earnings Summary - TradingView

ADC Therapeutics SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Earnings call transcript: ADC Therapeutics beats Q2 2026 estimates but shares fall - Investing.com

ADC Therapeutics Q2 2026 Earnings Call Transcript - Benzinga

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

ADC THERAPEUTICS SA -REDH ($ADCT) Releases Q2 2026 Earnings - Quiver Quantitative

ADC Therapeutics Q2 2026 Earnings: Lower Spending Narrows the Loss - TradingKey

ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates - Yahoo Finance

Earnings To Watch: ADC Therapeutics SA (ADCT) Q2 2026 -- GF Value Sees 125% Upside - GuruFocus

ADC Therapeutics SA expected to post a loss of 21 cents a shareEarnings Preview - TradingView

ADC Therapeutics SA (ADCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

ADC Therapeutics SA (ADCT) Stock News Today - TradingKey

ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026 - Morningstar

ADC Therapeutics (ADCT) to Post Quarterly Earnings on Tuesday - MarketBeat

BlackRock (NYSE: BLK) discloses 5.4% ownership of ADC Therapeutics (ADCT) - Stock Titan

ADC Therapeutics SA (ADCT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Orbimed Advisors LLC Has $4.94 Million Stock Position in ADC Therapeutics SA $ADCT - MarketBeat

ADC Therapeutics SA (ADCT) Income Statement - TradingKey

ADCT|ADC Therapeutics SA|Price:1.010|Chg%:-0.050 - TradingKey

ADC Therapeutics SA (ADCT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

ADC Therapeutics SA (ADCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

ADCT|ADC Therapeutics SA|Price:1.139|Chg%:-0.000 - TradingKey

ADCT|ADC Therapeutics SA|Price:1.150|Chg%:-0.045 - TradingKey

ADC Therapeutics SA (ADCT) Cash Flow - TradingKey

ADC Therapeutics SA (ADCT) Balance Sheet - TradingKey

ADC Therapeutics (ADCT) Drops 5.7% as Stock Nears Critical SupportCovered Call ETF - vinanet.vn

ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Finan - GuruFocus

ADC Therapeutics SA (NYSE:ADCT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Adc Therapeutics Sa Azioni (ADCT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ADCT